Abstract:Introduction A 36-year-old man with a history of cannabis use disorder since age 16, consuming 8-10 units/day, experienced irritability and tremors upon reducing consumption. His psychiatric issues emerged in 2020, marked by anxiety, abdominal pain, and severe vomiting, leading to a dyspepsia diagnosis. Subsequently, he received psychiatric care at CAS Hospitalet, diagnosed with severe cannabis use disorder. No prior inpatient admissions occurred. Objectives Our project aims to show a case report and summarize the available evidence on cannabinoid hyperemesis syndrome (CHS). Methods In May 2023, he voluntarily sought admission to Barcelona's "Hospital Sant Pau," aiming for cannabis detox and treatment of cannabinoid hyperemesis. He'd endured years of intense abdominal pain, nausea, and vomiting, worsening over the last two years, with uncontrollable vomiting hindering daily life. Admission saw reduced cannabis use to 3-4 units/day. Inpatient care revealed anticipatory anxiety, rumination, and somatic anxiety, accompanied by distal tremors and internal restlessness due to abdominal discomfort, partially alleviated by 5-10 mg of diazepam. Results Treatment included domperidone 10mg/8h, haloperidol drops (5-10 drops/8h), capsaicin ointment, hot showers, and cryotherapy, resulting in gradual relief from abdominal pain. Moderate cravings for tobacco and cannabis led to acetylcysteine 600mg/12h and gabapentin up to 1200mg/8h. Gastric discomfort with SSRIs led to vortioxetine 10 mg/day, well-tolerated with a positive response. Consultation with the GI department confirmed the treatment's efficacy, emphasizing cannabis abstinence. Upon discharge, cannabinoid hyperemesis symptoms markedly improved, and the patient was referred to "Hospital de Dia." Conclusions CHS is a cyclic vomiting syndrome, preceded by daily to weekly chronic longstanding use of cannabis that can be difficult to diagnose and treat(1,3,4). It is unique in presentation, because of the cannabis's biphasic effect as anti-emetic at low doses and pro-emetic at higher doses, and the association with pathological hot water bathing (2). The major characteristics are as follows: history of regular cannabis for any duration of time (100%), cyclic nausea and vomiting (100%), resolution of symptoms after stopping cannabis (96.8%), compulsive hot baths with symptom relief (92.3%), male predominance (72.9%), abdominal pain (85.1%), and at least weekly cannabis use (97.4%)(1). Treatments such as topical capsaicin, haloperidol, benzodiazepines, and propranolol have shown symptom relief (3) whereas opioids should be avoided (4). Cannabis cessation appears to be the best treatment (1,3). References 1. Sorensen et al. Journal of Medical Toxicology 13 (2017):71-87. 2. Perisetti et al. Annals of gastroenterology 33.6 (2020):571. 3. Senderovich et al. Medical Principles and Practice 31.1 (2022):29-38. 4. Leu, et al. Journal of Emergency Nursing 47.3 (2021): 483-486 Disclosure of Interest None Declared

Rare but relevant: Cannabinoid hyperemesis syndrome

Cannabinoid hyperemesis syndrome-an emerging gastrointestinal disorder and clinical challenge

Cannabinoids Hyperemesis Syndrome – An Urgent Call for Timely Diagnosis, Management, and Future Directions– A Case Report and Review of the Updated Literature

A Comprehensive Review and Update on Cannabis Hyperemesis Syndrome

Cannabis use patterns and association with hyperemesis: A comprehensive review

Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome

Cannabinoid syndrome in cannabis dependence: a case report

Cannabis Hyperemesis Syndrome in a Recently Abstinent Chronic User: Assessment and Intervention

How to have an acute gastroenteritis and an Anxiety Disorder at the same time: Cannabinoid hyperemesis syndrome (CHS) Case Series

RCEM best practice guideline: suspected cannabinoid hyperemesis syndrome in emergency departments

Cannabinoid hyperemesis syndrome co‐occurring with superior mesenteric artery syndrome in adolescents

Prevalence and trends of suspected cannabinoid hyperemesis syndrome over an 11-year period in Northern California: An electronic health record study

Cannabinoid Hyperemesis Syndrome Presumed Secondary to CBD Use: A Case Report

Contesting Cannabinoid Hyperemesis Syndrome: How Narratives of Cannabis Shape Diagnosis Contestation and Treatment Resistance

Distinguishing Clinical Features of Cannabinoid Hyperemesis Syndrome and Cyclic Vomiting Syndrome: A Retrospective Cohort Study

Cyclic vomiting syndrome: Future clinical and research priorities for: Special supplement/proceedings of 3rd international symposium

Acute care of cyclic vomiting syndrome and cannabinoid hyperemesis syndrome in the home and emergency department for: Special supplement/proceedings of 3rd international symposium

A Rare Complication of Cannabinoid Hyperemesis Syndrome

Endocannabinoid signaling in stress, nausea, and vomiting

An analysis of cannabinoid hyperemesis syndrome Reddit posts and themes

S2295 Increase in Acute Gastrointestinal Diagnoses Post-Recreational Cannabis Sales in Montana